Nano-zymography using laser-scanning confocal microscopy unmasks proteolytic activity of cell-derived microparticles

Theranostics

Volumn 6, Issue 5, 2016, Pages 610-626

  Briens, Aurélien ^a   Gauberti, Maxime ^a   Parcq, Jérôme ^a   Montaner, Joan ^b   Vivien, Denis ^a   de Lizarrondo, Sara Martinez ^a  

^a UNIVERSITÉ DE CAEN   (France)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Exosomes; Extracellular vesicles; Fibrinolysis; Inflammation; MPIO; Optical imaging; Phosphatidylserine

Indexed keywords

ALTEPLASE; PLASMIN; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE; PEPTIDE HYDROLASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY LABELING; ANTIGEN DETECTION; ARTICLE; BRAIN ISCHEMIA; CELL SURFACE; CONFOCAL LASER MICROSCOPY; CONTINUOUS INFUSION; CONTROLLED STUDY; FIBRINOLYTIC THERAPY; HUMAN; HUMAN CELL; MALE; MEMBRANE MICROPARTICLE; MOUSE; NANO ZYMOGRAPHY; NONHUMAN; PROTEIN DEGRADATION; ZYMOGRAPHY; ANIMAL; CEREBROVASCULAR ACCIDENT; CHEMISTRY; CONFOCAL MICROSCOPY; DISEASE MODEL; ENZYMOLOGY; PATHOLOGY; PLASMA; PROCEDURES;

ANIMALS; CELL-DERIVED MICROPARTICLES; DISEASE MODELS, ANIMAL; HUMANS; MICE; MICROSCOPY, CONFOCAL; PEPTIDE HYDROLASES; PLASMA; STROKE;

EID: 84964320845     PISSN: None     EISSN: 18387640     Source Type: Journal    
DOI: 10.7150/thno.13757     Document Type: Article

References (60)

1. Yanez-Mo M, Siljander PR, Andreu Z, Zavec AB, Borras FE, Buzas EI, et al. Biological properties of extracellular vesicles and their physiological functions. Journal of extracellular vesicles. 2015; 4: 27066.
2. Rothmeier AS, Marchese P, Petrich BG, Furlan-Freguia C, Ginsberg MH, Ruggeri ZM, et al. Caspase-1-mediated pathway promotes generation of thromboinflammatory microparticles. The Journal of clinical investigation. 2015; 125: 1471-84.
3. Mause SF, Weber C. Microparticles: protagonists of a novel communication network for intercellular information exchange. Circulation research. 2010; 107: 1047-57.
4. Owens AP, 3rd, Mackman N. Microparticles in hemostasis and thrombosis. Circulation research. 2011; 108: 1284-97.
5. Punyadee N, Mairiang D, Thiemmeca S, Komoltri C, Pan-Ngum W, Chomanee N, et al. Microparticles provide a novel biomarker to predict severe clinical outcomes of dengue virus infection. Journal of virology. 2015; 89: 1587-607.
6. Sarlon-Bartoli G, Bennis Y, Lacroix R, Piercecchi-Marti MD, Bartoli MA, Arnaud L, et al. Plasmatic level of leukocyte-derived microparticles is associated with unstable plaque in asymptomatic patients with high-grade carotid stenosis. Journal of the American College of Cardiology. 2013; 62: 1436-41.
7. Thomashow MA, Shimbo D, Parikh MA, Hoffman EA, Vogel-Claussen J, Hueper K, et al. Endothelial microparticles in mild chronic obstructive pulmonary disease and emphysema. The Multi-Ethnic Study of Atherosclerosis Chronic Obstructive Pulmonary Disease study. American journal of respiratory and critical care medicine. 2013; 188: 60-8.
8. Loyer X, Vion AC, Tedgui A, Boulanger CM. Microvesicles as cell-cell messengers in cardiovascular diseases. Circulation research. 2014; 114: 345-53.
9. Tian Y, Salsbery B, Wang M, Yuan H, Yang J, Zhao Z, et al. Brain-derived microparticles induce systemic coagulation in a murine model of traumatic brain injury. Blood. 2015; 125: 2151-9.
10. Lacroix R, Dignat-George F. Microparticles: new protagonists in pericellular and intravascular proteolysis. Seminars in thrombosis and hemostasis. 2013; 39: 33-9.
11. Canault M, Leroyer AS, Peiretti F, Leseche G, Tedgui A, Bonardo B, et al. Microparticles of human atherosclerotic plaques enhance the shedding of the tumor necrosis factor-alpha converting enzyme/ADAM17 substrates, tumor necrosis factor and tumor necrosis factor receptor-1. The American journal of pathology. 2007; 171: 1713-23.
12. Dejouvencel T, Doeuvre L, Lacroix R, Plawinski L, Dignat-George F, Lijnen HR, et al. Fibrinolytic cross-talk: a new mechanism for plasmin formation. Blood. 2010; 115: 2048-56.
13. Martinez de Lizarrondo S, Roncal C, Calvayrac O, Rodriguez C, Varo N, Purroy A, et al. Synergistic effect of thrombin and CD40 ligand on endothelial matrix metalloproteinase-10 expression and microparticle generation in vitro and in vivo. Arteriosclerosis, thrombosis, and vascular biology. 2012; 32: 1477-87.
14. Lacroix R, Plawinski L, Robert S, Doeuvre L, Sabatier F, Martinez de Lizarrondo S, et al. Leukocyte-and endothelial-derived microparticles: a circulating source for fibrinolysis. Haematologica. 2012; 97: 1864-72.
15. Perez-Casal M, Downey C, Fukudome K, Marx G, Toh CH. Activated protein C induces the release of microparticle-associated endothelial protein C receptor. Blood. 2005; 105: 1515-22.
16. Perez-Casal M, Downey C, Cutillas-Moreno B, Zuzel M, Fukudome K, Toh CH. Microparticle-associated endothelial protein C receptor and the induction of cytoprotective and anti-inflammatory effects. Haematologica. 2009; 94: 387-94.
17. Dolo V, D'Ascenzo S, Violini S, Pompucci L, Festuccia C, Ginestra A, et al. Matrix-degrading proteinases are shed in membrane vesicles by ovarian cancer cells in vivo and in vitro. Clinical & experimental metastasis. 1999; 17: 131-40.
18. Graves LE, Ariztia EV, Navari JR, Matzel HJ, Stack MS, Fishman DA. Proinvasive properties of ovarian cancer ascites-derived membrane vesicles. Cancer research. 2004; 64: 7045-9.
19. van der Pol E, Coumans F, Varga Z, Krumrey M, Nieuwland R. Innovation in detection of microparticles and exosomes. Journal of thrombosis and haemostasis: JTH. 2013; 11 Suppl 1: 36-45.
20. Arraud N, Gounou C, Linares R, Brisson AR. A simple flow cytometry method improves the detection of phosphatidylserine-exposing extracellular vesicles. Journal of thrombosis and haemostasis: JTH. 2015; 13: 237-47.
21. van der Pol E, Coumans FA, Grootemaat AE, Gardiner C, Sargent IL, Harrison P, et al. Particle size distribution of exosomes and microvesicles determined by transmission electron microscopy, flow cytometry, nanoparticle tracking analysis, and resistive pulse sensing. Journal of thrombosis and haemostasis: JTH. 2014; 12: 1182-92.
22. Gauberti M, Martinez de Lizarrondo S, Orset C, Vivien D. Lack of secondary microthrombosis after thrombin-induced stroke in mice and non-human primates. Journal of thrombosis and haemostasis: JTH. 2014; 12: 409-14.
23. Gakuba C, Gauberti M, Mazighi M, Defer G, Hanouz JL, Vivien D. Preclinical evidence toward the use of ketamine for recombinant tissue-type plasminogen activator-mediated thrombolysis under anesthesia or sedation. Stroke; a journal of cerebral circulation. 2011; 42: 2947-9.
24. Le Behot A, Gauberti M, Martinez De Lizarrondo S, Montagne A, Lemarchand E, Repesse Y, et al. GpIbalpha-VWF blockade restores vessel patency by dissolving platelet aggregates formed under very high shear rate in mice. Blood. 2014; 123: 3354-63.
25. Montagne A, Gauberti M, Macrez R, Jullienne A, Briens A, Raynaud JS, et al. Ultra-sensitive molecular MRI of cerebrovascular cell activation enables early detection of chronic central nervous system disorders. NeuroImage. 2012; 63: 760-70.
26. Mendioroz M, Fernandez-Cadenas I, Rosell A, Delgado P, Domingues-Montanari S, Ribo M, et al. Osteopontin predicts long-term functional outcome among ischemic stroke patients. Journal of neurology. 2011; 258: 486-93.
27. Gauberti M, Montagne A, Marcos-Contreras OA, Le Behot A, Maubert E, Vivien D. Ultra-sensitive molecular MRI of vascular cell adhesion molecule-1 reveals a dynamic inflammatory penumbra after strokes. Stroke; a journal of cerebral circulation. 2013; 44: 1988-96.
28. Melemenidis S, Jefferson A, Ruparelia N, Akhtar AM, Xie J, Allen D, et al. Molecular magnetic resonance imaging of angiogenesis in vivo using polyvalent cyclic RGD-iron oxide microparticle conjugates. Theranostics. 2015; 5: 515-29.
29. Jefferson A, Ruparelia N, Choudhury RP. Exogenous microparticles of iron oxide bind to activated endothelial cells but, unlike monocytes, do not trigger an endothelial response. Theranostics. 2013; 3: 428-36.
30. Gauberti M, Montagne A, Quenault A, Vivien D. Molecular magnetic resonance imaging of brain-immune interactions. Frontiers in cellular neuroscience. 2014; 8: 389.
31. Deutsch DG, Mertz ET. Plasminogen: purification from human plasma by affinity chromatography. Science (New York, NY). 1970; 170: 1095-6.
32. Nieuwland R, Berckmans RJ, Rotteveel-Eijkman RC, Maquelin KN, Roozendaal KJ, Jansen PG, et al. Cell-derived microparticles generated in patients during cardiopulmonary bypass are highly procoagulant. Circulation. 1997; 96: 3534-41.
33. Lacroix R, Sabatier F, Mialhe A, Basire A, Pannell R, Borghi H, et al. Activation of plasminogen into plasmin at the surface of endothelial microparticles: a mechanism that modulates angiogenic properties of endothelial progenitor cells in vitro. Blood. 2007; 110: 2432-9.
34. Wang JG, Williams JC, Davis BK, Jacobson K, Doerschuk CM, Ting JP, et al. Monocytic microparticles activate endothelial cells in an IL-1beta-dependent manner. Blood. 2011; 118: 2366-74.
35. Bernimoulin M, Waters EK, Foy M, Steele BM, Sullivan M, Falet H, et al. Differential stimulation of monocytic cells results in distinct populations of microparticles. Journal of thrombosis and haemostasis: JTH. 2009; 7: 1019-28.
36. Connor DE, Exner T, Ma DD, Joseph JE. The majority of circulating platelet-derived microparticles fail to bind annexin V, lack phospholipid-dependent procoagulant activity and demonstrate greater expression of glycoprotein Ib. Thrombosis and haemostasis. 2010; 103: 1044-52.
37. Belliere J, Martinez de Lizarrondo S, Choudhury RP, Quenault A, Le Béhot A, Delage C, et al. Unmasking Silent Endothelial Activation in the Cardiovascular System Using Molecular Magnetic Resonance Imaging. Theranostics. 2015; 5: 1187-202.
38. Lojda Z. The use of substrates with 7-amino-3-trifluoromethylcoumarine (AFC) leaving group in the localization of protease activities in situ. Acta histochemica. 1996; 98: 215-28.
39. Lemarchand E, Gauberti M, Martinez de Lizarrondo S, Villain H, Repesse Y, Montagne A, et al. Impact of alcohol consumption on the outcome of ischemic stroke and thrombolysis: role of the hepatic clearance of tissue-type plasminogen activator. Stroke; a journal of cerebral circulation. 2015; 46: 1641-50.
40. Hell SW, Wichmann J. Breaking the diffraction resolution limit by stimulated emission: stimulated-emission-depletion fluorescence microscopy. Optics letters. 1994; 19: 780-2.
41. Hanne J, Falk HJ, Gorlitz F, Hoyer P, Engelhardt J, Sahl SJ, et al. STED nanoscopy with fluorescent quantum dots. Nature communications. 2015; 6: 7127.
42. Bertram A, Lovric S, Engel A, Beese M, Wyss K, Hertel B, et al. Circulating ADAM17 Level Reflects Disease Activity in Proteinase-3 ANCA-Associated Vasculitis. Journal of the American Society of Nephrology: JASN. 2015.
43. Lee JH, Wittki S, Brau T, Dreyer FS, Kratzel K, Dindorf J, et al. HIV Nef, paxillin, and Pak1/2 regulate activation and secretion of TACE/ADAM10 proteases. Molecular cell. 2013; 49: 668-79.
44. Taraboletti G, D'Ascenzo S, Borsotti P, Giavazzi R, Pavan A, Dolo V. Shedding of the matrix metalloproteinases MMP-2, MMP-9, and MT1-MMP as membrane vesicle-associated components by endothelial cells. The American journal of pathology. 2002; 160: 673-80.
45. Vandooren J, Geurts N, Martens E, Van den Steen PE, Opdenakker G. Zymography methods for visualizing hydrolytic enzymes. Nature methods. 2013; 10: 211-20.
46. Lee S, Kim K. Protease activity: meeting its theranostic potential. Theranostics. 2012; 2: 125-6.
47. Wosnick JH, Mello CM, Swager TM. Synthesis and application of poly(phenylene ethynylene)s for bioconjugation: a conjugated polymer-based fluorogenic probe for proteases. Journal of the American Chemical Society. 2005; 127: 3400-5.
48. Lv Y, Xue Q, Gu X, Zhang S, Liu J. A label-free fluorescence assay for thrombin based on aptamer exonuclease protection and exonuclease III-assisted recycling amplification-responsive cascade zinc(II)-protoporphyrin IX/G-quadruplex supramolecular fluorescent labels. The Analyst. 2014; 139: 2583-8.
49. Huang Y, Hu K, Zhao S, Li M, Chen ZF, Lv Q, et al. Carbon nanotube-enhanced polarization of fluorescent peptides: a novel amplification strategy for homogeneous detection of proteases. Chemistry, an Asian journal. 2014; 9: 87-92.
50. Wehman AM, Poggioli C, Schweinsberg P, Grant BD, Nance J. The P4-ATPase TAT-5 inhibits the budding of extracellular vesicles in C. elegans embryos. Current biology: CB. 2011; 21: 1951-9.
51. Larson MC, Woodliff JE, Hillery CA, Kearl TJ, Zhao M. Phosphatidylethanolamine is externalized at the surface of microparticles. Biochimica et biophysica acta. 2012; 1821: 1501-7.
52. Satta N, Toti F, Feugeas O, Bohbot A, Dachary-Prigent J, Eschwege V, et al. Monocyte vesiculation is a possible mechanism for dissemination of membrane-associated procoagulant activities and adhesion molecules after stimulation by lipopolysaccharide. Journal of immunology (Baltimore, Md: 1950). 1994; 153: 3245-55.
53. Simak J, Holada K, Vostal JG. Release of annexin V-binding membrane microparticles from cultured human umbilical vein endothelial cells after treatment with camptothecin. BMC cell biology. 2002; 3: 11.
54. Zhang Y, Meng H, Ma R, He Z, Wu X, Cao M, et al. Circulating Microparticles, Blood Cells and Endothelium Induce Procoagulant Activity in Sepsis Through Phosphatidylserine Exposure. Shock (Augusta, Ga). 2015.
55. Vivien D, Gauberti M, Montagne A, Defer G, Touze E. Impact of tissue plasminogen activator on the neurovascular unit: from clinical data to experimental evidence. Journal of cerebral blood flow and metabolism: official journal of the International Society of Cerebral Blood Flow and Metabolism. 2011; 31: 2119-34.
56. Perez-Casal M, Thompson V, Downey C, Welters I, Wyncoll D, Thachil J, et al. The clinical and functional relevance of microparticles induced by activated protein C treatment in sepsis. Critical care (London, England). 2011; 15: R195.
57. Declerck PJ, Gils A. Three decades of research on plasminogen activator inhibitor-1: a multifaceted serpin. Seminars in thrombosis and hemostasis. 2013; 39: 356-64.
58. Herz J, Strickland DK. LRP: a multifunctional scavenger and signaling receptor. The Journal of clinical investigation. 2001; 108: 779-84.
59. Doeuvre L, Plawinski L, Goux D, Vivien D, Angles-Cano E. Plasmin on adherent cells: from microvesiculation to apoptosis. The Biochemical journal. 2010; 432: 365-73.
60. Zhu H, Fan X, Yu Z, Liu J, Murata Y, Lu J, et al. Annexin A2 combined with low-dose tPA improves thrombolytic therapy in a rat model of focal embolic stroke. Journal of cerebral blood flow and metabolism: official journal of the International Society of Cerebral Blood Flow and Metabolism. 2010; 30: 1137-46.